Bristol Myers Squibb doles out $8M in new grants to improve health equity with cardiovascular, oncology focus

Bristol Myers Squibb is earmarking nearly $8 million in new grants to two dozen nonprofits focused on improving access to healthcare in underserved communities.

The latest round of grants is part of the company’s 2020 pledge to donate $150 million over the next five years to organizations focused on reducing health disparities. So far, the company has donated more than $39 million, including the funds announced Tuesday. The grants, which tend to range from one to three years, are aimed at supporting four therapeutic areas: cardiovascular disease, hematology, immunology and oncology.